SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report
SEC Accession No. 0001424884-11-000031
Filing Date
2011-03-02
Accepted
2011-03-02 14:09:22
Documents
7
Period of Report
2011-03-02
Filing Date Changed
2011-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FROM 8-K form8-k.htm 8-K 32720
2 FORM OF SECURITIES PURCHASE AGREEMENT exhibit10-1.htm EX-10.1 75701
3 FORM OF CONVERTIBLE NOTE exhibit10-2.htm EX-10.2 49627
4 FORM OF SECURITY AGREEMENT exhibit10-3.htm EX-10.3 86035
5 FORM OF WARRANT exhibit10-4.htm EX-10.4 92846
6 PRESS RELEASE ENTITLED ?TAPIMMUNE CLOSES $1.13 MILLION FUNDING: COMPANY RETIRES exhibit99-1.htm EX-99.1 10765
7 TAPIMMUNE LOGO exhibit99-10.jpg GRAPHIC 4388
  Complete submission text file 0001424884-11-000031.txt   355344
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27239 | Film No.: 11655521
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1